Compositions for Identifying Novel Compositions for the Treatment of Disease and Methods of Using Same
作者： Yolanda Sanchez , Matthew Duncan Wood , Nancy Ratner
DOI:
关键词:
摘要: Disclosed herein are compositions useful for identification of potential therapeutic agents the treatment a disorder associated with RAS deregulation or dysregulation. The may be yeast cell having one more mutations in an IRA gene ERG gene. Also disclosed methods using these compositions.
lens.org 参考文章(15)
John P. Manfredi, Meng-Yu Wu, Benjamin K. Benton, Cell having amplified signal transduction pathway responses and uses therefor ,(2002)
David Gutmann, Jason Weber, Methods for treating neurofibromatosis 1 ,(2006)
Lambertus J. Oehlen, System for detection of a functional interaction between a compound and a cellular signal transduction component ,(2003)
Mary Cismowski, Lauren Silverman, Kirill Ostanin, Cell surface proteins and use thereof as indicators of activation of cellular signal transduction pathways ,(2003)
Deborah Tardy Chaleff, Eileen Marie Kajkowski, John Richard Hadcock, Laura Alicia Price, Mark Henry Pausch, Bradley Alton Ozenberger, Donald Richard Kirsch, Heterologous G protein coupled receptors expressed in yeast, their fusion with G proteins and use thereof in bioassay ,(1995)
Kappei Tsukahara, Kaoru Mitsuhashi, Method of gene screening with yeast having ergosterol synthase undergoing inducible expression ,(2005)
Edward R. Lavallie, John Mccoy, Peptide and protein fusions to thioredoxin and thioredoxin-like molecules ,(1992)
Lauren Silverman, Kirill Ostanin, Yeast cells having mutations in stp22 and uses therefor ,(1999)
Bryan McKibben, Arlindo L. Castelhano, Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds ,(1997)
Joshua Trueheart, Dana M. Fowlkes, Andrew J. M. Murphy, James R. Broach, Jeremy I. Paul, John P. Manfredi, Christine A. Klein, Yeast cells expressing modified G proteins and methods of use therefor ,(2004)